Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo UMR Virologie logo INRAE logo Anses logo ENVA

UMR 1161 Virologie

ZEN

The ZEN team (Equine Zoonoses and NeuroVirology) studies flavivirus, bornavirus and alphavirus virulence. Those viruses are emerging and re-emerging zoonotic neurotropic viruses of medical and veterinary significance. The ZEN team is divided in two groups working cohesively and collaboratively to ensure a comprehensive understanding of the pathobiology and epidemiology of these viruses, to develop new diagnostic tools, and to identify potential therapeutic or preventive strategies.

Currently, three Flaviviruses and one Alphavirus constitute the main research targets: West Nile Virus (WNV), USUTU Virus (USUV), tick-borne-encephalitis virus (TBEV) and the Eastern equine encephalitis virus (EEEV). In France, and throughout Europe, WNV is a recurrent sanitary problem. Its close relative, USUV has rapidly spread through the French territory over the past few years, causing bird mortalities and occasional human and equine neurological diseases. TBEV is transmitted to animals and humans via tick bites, but it can also be found in goat milk and several outbreaks of TBEV infections can be caused by the consumption of unpasteurized goat dairy products. EEEV is an alphavirus which is also responsible for neurological diseases in human and horses. It is currently restricted to America.

Our missions:

As European Reference Laboratory (EURL) for Equine diseases, ZEN has the mission to ensure the high quality, uniform, and reliable the testing of West Nile Virus and Equine Viral Encephalitis (Eastern, Western and Venezuelan equine encephallomyelitis) carried out by all the European national reference laboratories (NRL) in the network. Trainings sessions are provided as needed to researchers throughout Europe. We also develop methods that are then transferred to the accredited laboratories. Finally, once a year, ZEN organizes a workshop to discuss results of National Reference Laboratory analyses, and provide advices and ways of improvements.

Link to the EURL Website: https://eurl-equinediseases.anses.fr

As National Reference Laboratory (NRL), ZEN has the mission to ensure the diagnostic of African Horse sickness (AHS), West Nile Fever (and other emerging flaviviruses), and Equine Viral Encephalitis. Most of these viruses have an enzootic cycle and are zoonotic and neurotropic in equine and humans. ZEN is at the head of a network of 7 laboratories located across the country. To that extent, we have to confirm results coming from this network and to continuously develop better diagnostic tools, that guarantee faster and more reliable results.

Rapid risk assessment: Following outbreaks, ZEN rapidly develops new tools, methodologies and research projects in order to fill knowledge gaps on emerging viruses pathobiology and epidemiology to allow the Agency to assess the resulting risk of exposure. Expert team members also share their expertise through on-going discussions with ANSES experts committees providing risk assessments in animal health and welfare and in food biological safety.

Research axes:

Nolwenn’s group – Virus ecology and evolution

- Epidemiology. We develop national surveillance programs to track virus geographic distribution and identify the anthropogenic and environmental factors that contribute to disease emergence and spread.

- Evolution. We use next generation sequencing approaches to discover and characterize novel viruses, and to track virus evolution overtime, thus identifying ecological determinants of virus cross-species transmission and dispersion.

- Characterize viruses’ transmission cycles. We assess host exposure through field studies using both wild and captive animals. We also evaluate host competency and virus transmission modes through experimental infections.

- Viral determinants of pathogenicity, transmission and virulence. We use a combination of in vitro and in vivo experiments to assess differences in the pathogenicity and transmission of different viral strains and species. The viral molecular determinants of differences are characterized through a combination of interatomic (Y2H), proteomics, and transcriptomics. Finally, chimeric and mutant viruses are engineered to confirm the role of specific genomic regions.

- Identification of antiviral molecules. The group has develop an in vitro technique based on Xcelligence to screen for antiviral molecules and employs in vivo approaches to test the toxicity of identified molecules in equine.

- Role of other parasites in host susceptibility to viruses. We use a combination of field studies and in vivo experiments to test the role of the microbiome, and the impact of co-infection with other organisms (bacteria, viruses, parasites) on host immune response to infection, and virus pathogenicity, transmission, and evolution.

Muriel’s group – Neuropathology and antivirals

image_zen_cellules_pour_site

- Understand neuropathogenicity. We use human and equine primary-type cell culture - 2D and 3D (cerebral organoids) cultures of the central nervous system derived from fetal neural progenitor cells or induced pluripotent stem cells – to address the mechanisms by which neurotropic viruses damage the human and equine brains. The role of cell-type specific immune response as well as cellular factors involved in neuronal death and viral replication in the brain are investigated.  

- Search for antiviral therapies.  Our goal is to identify antiviral molecules that prevent the replication of Flavivirus and Alphavirus in the human and equine brains as well as to unravel their mechanism of action. To this aim, we use recently developed screens and tests of high predictive value (based on 2D/3D-human and equine primary-type neural cells and image analysis

Our members :

  • Head :

Muriel Coulpier (INRAE)

Nolwenn M Dheilly (ANSES)

  •  Scientific Staff :

Gaëlle Gonzalez (ANSES, head of WNV NRL)

Camille Migne (ANSES)

  • Technical and Administrative Staff

Rayane Amaral Moraes (ANSES)

female-avatar-profile-picture-silhouette-light-vector-5351521

Marielle Cochet (AI, INRAE)

Marine Dumarest (ANSES)

Kamila Gorna (Tech, ANSES)

Francois_PIUMI

François Piumi (IE, INRAE)

  • Postdoctoral Researcher :

Noémie Berry (INRAE)

  • PhD Candidate

Lise Fiacre (ANSES/CIRAD), Marielle Cochet (INRAE)

  • Temporary Staff :

Valentine Chaillot (Master Student)

Aicha Dembele (Tech, INRAE)